News

US FDA approves gradual dosing for Lilly Alzheimer's drug
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
MyChesCo on MSN3h
Larimar Therapeutics Advances Friedreich’s Ataxia Program with New Publications on Nomlabofusp Data
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced the publication of two new peer-reviewed articles ...
National Law Review4h
FDA Begins Public Comment Period on Method for Ranking Chemicals in Food for Post-Market Assessments
The U.S. Food and Drug Administration (FDA) announced on June 18, 2025, the release of its proposed method for ranking ...
STAT18h
Pharmalittle: We’re reading about Medicare drug negotiations, a Novartis malaria drug, and more
The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...
Healio23h
Alcon to acquire LumiThera and its photobiomodulation device for dry AMD
This is a developing news story. Please check back soon for updates. Alcon will acquire LumiThera, including its ...